CIRSE Standards of Practice on Transjugular Intrahepatic Portosystemic Shunts.

IF 2.8 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

CardioVascular and Interventional Radiology Pub Date : 2024-11-17 DOI:10.1007/s00270-024-03866-y

Pierleone Lucatelli, Antonín Krajina, Romaric Loffroy, Roberto Miraglia, Claus Christian Pieper, Stéphanie Franchi-Abella, Bianca Rocco

{"title":"CIRSE Standards of Practice on Transjugular Intrahepatic Portosystemic Shunts.","authors":"Pierleone Lucatelli, Antonín Krajina, Romaric Loffroy, Roberto Miraglia, Claus Christian Pieper, Stéphanie Franchi-Abella, Bianca Rocco","doi":"10.1007/s00270-024-03866-y","DOIUrl":null,"url":null,"abstract":"Background: Proposed in the early 1980s as a solution for managing complications of portal hypertension, the percutaneous creation of transjugular intrahepatic portosystemic shunt has consistently gained a central role. Increasingly lower complication rates have been observed thanks to improvements in both technologies and the skills of interventional radiologists.Purpose: This document is aimed at interventional radiologists and provides best practice recommendations for transjugular intrahepatic portosystemic shunt creation, describing patient selection, intraprocedural management and follow-up, in addition to recommendations in paediatric settings.Methods: The CIRSE Standards of Practice Committee established a writing group consisting of seven European clinicians with recognised expertise in the creation of transjugular intrahepatic portosystemic shunt. The writing group reviewed the existing literature performing a pragmatic evidence search using PubMed to select relevant publications in the English language and involving human subjects, preferably published from 2009 to 2024. The final recommendations were developed by consensus.Results: TIPS creation has an established role in the successful management of portal hypertension and its complications. This Standards of Practice document provides up-to-date recommendations for patient selection, materials, its safe performance, and follow-up with complications management.","PeriodicalId":9591,"journal":{"name":"CardioVascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CardioVascular and Interventional Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00270-024-03866-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Proposed in the early 1980s as a solution for managing complications of portal hypertension, the percutaneous creation of transjugular intrahepatic portosystemic shunt has consistently gained a central role. Increasingly lower complication rates have been observed thanks to improvements in both technologies and the skills of interventional radiologists.

Purpose: This document is aimed at interventional radiologists and provides best practice recommendations for transjugular intrahepatic portosystemic shunt creation, describing patient selection, intraprocedural management and follow-up, in addition to recommendations in paediatric settings.

Methods: The CIRSE Standards of Practice Committee established a writing group consisting of seven European clinicians with recognised expertise in the creation of transjugular intrahepatic portosystemic shunt. The writing group reviewed the existing literature performing a pragmatic evidence search using PubMed to select relevant publications in the English language and involving human subjects, preferably published from 2009 to 2024. The final recommendations were developed by consensus.

Results: TIPS creation has an established role in the successful management of portal hypertension and its complications. This Standards of Practice document provides up-to-date recommendations for patient selection, materials, its safe performance, and follow-up with complications management.

查看原文本刊更多论文

CIRSE 经颈静脉肝内门体分流术实践标准。

背景：经皮穿刺经颈静脉肝内门体分流术于 20 世纪 80 年代初提出，是治疗门静脉高压并发症的一种方法，并一直占据着重要地位。目的：本文件面向介入放射医师，提供经颈静脉肝内门体分流术的最佳实践建议，包括患者选择、术中管理和随访，以及儿科方面的建议：CIRSE 实践标准委员会成立了一个写作小组，由七位在经颈静脉肝内门体分流术方面具有公认专业知识的欧洲临床医生组成。编写小组使用 PubMed 对现有文献进行了务实的证据搜索，挑选出 2009 年至 2024 年期间发表的以英语撰写、涉及人体的相关出版物。最终的建议是在达成共识的基础上制定的：结果：TIPS 手术在成功治疗门静脉高压及其并发症方面发挥了重要作用。本实践标准文件提供了关于患者选择、材料、安全实施和并发症管理随访的最新建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CardioVascular and Interventional Radiology 医学-核医学

CiteScore

5.50

自引率

13.80%

发文量

306

审稿时长

3-8 weeks

期刊介绍： CardioVascular and Interventional Radiology (CVIR) is the official journal of the Cardiovascular and Interventional Radiological Society of Europe, and is also the official organ of a number of additional distinguished national and international interventional radiological societies. CVIR publishes double blinded peer-reviewed original research work including clinical and laboratory investigations, technical notes, case reports, works in progress, and letters to the editor, as well as review articles, pictorial essays, editorials, and special invited submissions in the field of vascular and interventional radiology. Beside the communication of the latest research results in this field, it is also the aim of CVIR to support continuous medical education. Articles that are accepted for publication are done so with the understanding that they, or their substantive contents, have not been and will not be submitted to any other publication.